Millie Hughes-Fulford, PhD

Millie Hughes-Fulford, PhD

Professor, Department of Biochemistry and Biophysics, UCSF; and Director, Laboratory of Cell Growth, VAMC/UCSF

Phone: 415) 221-4810 x2749 (voice)
VAMC 151F, San Francisco, CA 94143

View on UCSF Profiles

Cancer Center Membership

Associate Member » Prostate Cancer» Cancer Genetics


Tarleton State University, Stephenville, TX, B.S., 1968, Chemistry and Biology
Texas Women's University, Denton, TX, Ph.D., 1972, Radiation Chemistry
Woods Hole, Post-Graduate Training, 1987, Summer Physiology courses; 1999, Microscopy course

Professional Experience

  • 1973-1985
    Research Chemist, VAMC San Francisco, CA
  • 1977-1984
    Adjunct Assistant Professor; Biochemistry, Department of Medicine; University of California, San Francisco; and San Francisco Extension Faculty, Biochemistry, UC Berkeley
  • 1984-1991
    Astronaut Scientist, Spacelab Life Sciences-l, JSC, Houston
  • 1984-1994
    Adjunct Associate Professor of Biochemistry, Dept. of Medicine, UCSF, San Francisco
  • 1995- 2001
    Deputy Associate Chief of Staff for Education VAMCSF
  • 1991-present
    Scientific Advisor to the Undersecretary of the Department of Veteran's Affairs
  • 1993-present
    Director, Laboratory of Cell Growth, VAMC/UCSF
  • 1993-present
    Scientific Advisor to the UnderSecretary, Dept of Veteran's Affairs, Washington, DC
  • 1994-present
    Adjunct Professor in Medicine, Dept. of Medicine, UCSF, San Francisco
  • 1996-present
    Research Scientist, NCIRE
  • 2001-present
    Principal Medical Investigator, VAMC

Honors & Awards

  • 1965
    National Science Foundation Summer Research Fellow (Undergraduate)
  • 1968-1971
    National Science Foundation Fellowship (Graduate)
  • 1971-1972
    American Association of University Women's Fellowship
  • 1984
    Presidential Award for Federal Employee for Western Region
  • 1995
    Woman of the Year Marin county
  • 1995
    Named International Zontian, 1995

Selected Publications

  1. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc. 2015; 4(8).
    View on PubMed
  2. Spaceflight alters expression of microRNA during T-cell activation. FASEB J. 2015 Dec; 29(12):4893-900.
    View on PubMed
  3. Spaceflight impairs antigen-specific tolerance induction in vivo and increases inflammatory cytokines. FASEB J. 2015 Oct; 29(10):4122-32.
    View on PubMed
  4. Spaceflight and simulated microgravity cause a significant reduction of key gene expression in early T-cell activation. Am J Physiol Regul Integr Comp Physiol. 2015 Mar 15; 308(6):R480-8.
    View on PubMed
  5. Molecular mechanisms underlying the enhanced functions of three-dimensional hepatocyte aggregates. Biomaterials. 2014 Feb; 35(7):2162-71.
    View on PubMed
  6. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med. 2013 Oct; 18(5):263-74.
    View on PubMed
  7. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci Rep. 2013; 3:1494.
    View on PubMed
  8. Can I take a space flight? Considerations for doctors. BMJ. 2012; 345:e8124.
    View on PubMed
  9. The Rel/NF-?B pathway and transcription of immediate early genes in T cell activation are inhibited by microgravity. J Leukoc Biol. 2012 Dec; 92(6):1133-45.
    View on PubMed
  10. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res. 2012 Sep; 177(1):e35-43.
    View on PubMed
  11. Polyunsaturated fatty acids and peripheral artery disease. Vasc Med. 2012 Feb; 17(1):51-63.
    View on PubMed
  12. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004.
    View on PubMed
  13. To infinity ... and beyond! Human spaceflight and life science. FASEB J. 2011 Sep; 25(9):2858-64.
    View on PubMed
  14. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J Orthop Surg Res. 2011; 6:8.
    View on PubMed
  15. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50.
    View on PubMed
  16. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng Part A. 2009 Mar; 15(3):559-67.
    View on PubMed
  17. Glycosylation regulates turnover of cyclooxygenase-2. FEBS Lett. 2006 Dec 11; 580(28-29):6533-6.
    View on PubMed
  18. Reduction of anabolic signals and alteration of osteoblast nuclear morphology in microgravity. J Cell Biochem. 2006 Oct 1; 99(2):435-49.
    View on PubMed
  19. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells. J Bone Miner Res. 2006 Jun; 21(6):946-55.
    View on PubMed
  20. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res. 2006 Feb 1; 66(3):1427-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI